Article
Supporting evidence-based analysis for modified risk tobacco products through a toxicology data-sharing infrastructure
2017-09-05
Abstract excerpt
The US FDA defines modified risk tobacco products (MRTPs) as products that aim to reduce harm or the risk of tobacco-related disease associated with commercially marketed tobacco products. Establishing a product’s potential as an MRTP requires scientific substantiation including toxicity studies and measures of disease risk relative to those of cigarette smoking. Best practices encourage verification of the data...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5862657b-1797-5abd-ac05-1090e9ee3aaa
- DOI
- 10.12688/f1000research.10493.2
